Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 5, 2007, Pages

  Ranalletta, Mollie ^a   Xiu, Quan Du ^a   Seki, Yoshinori ^a   Glenn, Alan S ^a   Kruse, Michael ^a   Fiallo, Ariana ^a   Estrada, Irma ^a   Tsao, Tsu Shuen ^a   Stenbit, Antine E ^a   Katz, Ellen B ^a   Charron, Maureen J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Hepatic fatty acid synthesis; Muscle mitochondria; Substrate utilization

Indexed keywords

GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; EMBRYO; FAST MUSCLE; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; LIPID METABOLISM; LIVER METABOLISM; MALE; MOUSE; MUSCLE METABOLISM; NONHUMAN; NULL ALLELE; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; SKELETAL MUSCLE; SOLEUS MUSCLE; TRANSGENE;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE FIBERS, FAST-TWITCH; MUSCLE, SKELETAL; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 36148929788     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00628.2006     Document Type: Article

References (39)

1. Banzet S, Koulmann N, Sanchez H, Serruier B, Peinnequin A, Bigard AX. Musclin gene expression is strongly related to fast-glycolytic phenotype. Biochem Biophys Res Commun 353: 713-718, 2007.
2. Binas B, Han XX, Erol E, Luiken JJ, Glatz JF, Dyck Motazavi R DJ, Adihetty Hood DA PJ, Bonen. A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism. Am J Physiol Endocrinol Metab 285: E481-E489, 2003.
3. Bonen A, Han XX, Habets DDJ, Febbraio M, Glatz JFC, Luiken JJ. A null mutation in skeletal muscle FT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am J Physiol Endocrinol Metab 292: E1740-E1749, 2007.
4. Booth FW, Thomason DB. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 71: 541-585, 1991.
5. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559-569, 1998.
6. Cabezas H, Raposo RR, Melendez-Hevia E. Activity and metabolic roles of the pentose phosphate cycle in several rat tissues. Mol Cell Biochem 201: 57-63, 1999.
7. Cariou B, Postic C, Boudou P, Burcelin R, Kahn CR, Girard J, Burnol AF, Mauvais-Jarvis F. Cellular and molecular mechanisms of adipose tissue plasticity in muscle insulin receptor knockout mice. Endocrinology 145: 1926-1932, 2004.
8. Cohen P, Ntambi JM, Friedman JM. Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 3: 271-80, 2003.
9. Constable SH, Favier RJ, McLane JA, Fell RD, Chen M, Holloszy JO. Energy metabolism in contracting rat skeletal muscle: adaptation to exercise training. Am J Physiol Cell Physiol 253: C316-C322, 1987.
10. Dentin R, Denechaud PD, Benhamed F, Girard J, Postic C. Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP. J Nutr 136: 1145-1149, 2006.
11. Friedman JE, Sherman WM, Reed MJ, Elton CW, Dohm GL. Exercise training increases glucose transporter protein GLUT-4 in skeletal muscle of obese Zucker (fa/fa) rats. FEBS Lett 268: 13-16, 1990.
12. Fueger PT, Shearer J, Bracy DP, Posey KA, Pencek RR, McGuinness OP, Wasserman DH. Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice. J Physiol 562: 925-935, 2005.
13. Goodyear LJ, Hirshman MF, Valyou PM, Horton ES. Glucose transporter number, function, and subcellular distribution in rat skeletal muscle after exercise training. Diabetes 41: 1091-1099, 1992.
14. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831-838, 1984.
15. Irrcher I, Adhihetty PJ, Joseph AM, Ljubicic V, Hood DA. Regulation of mitochondrial biogenesis in muscle by endurance exercise. Sports Med 33: 783-793, 2003.
16. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151-155, 1995.
17. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, Breslow JL, Shulman GI. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 98: 7522-7527, 2001.
18. Kotani K, Peroni OD, Minokoshi Y, Boss O, Kahn BB. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J Clin Invest 114: 1666-1675, 2004.
19. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP. PGC-1 alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3: 0673- 0687, 2005.
20. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45: 23-27, 1996.
21. Lin X, Schonfeld G, Yue P, Chen Z. Hepatic fatty acid synthesis is suppressed in mice with fatty livers due to targeted apolipoprotein B38.9 mutation. Arterioscler Thromb Vasc Biol 22: 476-482, 2002.
22. Miura S, Kai Y, Ono M, Ezaki O. Overexpression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha down-regulates GLUT4 mRNA in skeletal muscles. J Biol Chem 278: 31385-31390, 2003.
23. Nishizawa H, Matsuda M, Yamada Y, Kawai K, Suzuki E, Makishima M, Kitamura T, Shimomura I. Musclin, a novel skeletal muscle-derived secretory factor. J Biol Chem 279: 19391-19395, 2004.
24. Nisoli E, Clementi E, Moncada S, Carruba MO. Mitochondrial biogenesis as a cellular signaling framework. Biochem Pharmacol 67: 1-15, 2004.
25. Pederson BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 42: 105-117, 2006.
26. Puigserver P. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-. Int J Obes 29:S5-S9, 2005.
27. Ranalletta M, Jiang H, Li J, Tsao TS, Stenbit AE, Yokoyama M, Katz EB, Charron MJ. Altered hepatic and muscle substrate utilization provoked by GLUT4 ablation. Diabetes 54: 935-943, 2005.
28. Ren JM, Semenkovich CF, Gulve EA, Gao J, Holloszy JO. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem 269: 14396-14401, 1994.
29. Ruderman NB, Keller C, Richard AM, Saha AK, Luo Z, Siang X, Giralt M, Ritov VB, Menshikova EV, Kelly DP, Hidalgo J, Pederson BK, Kelly M. Interleukin6 reegulation of AMP-activated protein kinase. Diabetes 55: S48-S54, 2006.
30. Schenk G, Duggleby RG, Nixon PF. Properties and functions of the thiamin diphosphate dependent enzyme transketolase. Int J Biochem Cell Biol 30: 1297-1318, 1998.
31. Steegs K, Oerlemans F, de Haan A, Heerschap A, Verdoodt L, de Bie M, Ruitenbeek W, Benders A, Jost C, van Deursen J, Tullson P, Terjung R, Jap P, Jakoob W, Pette D, Wieringa B. Cytoarchitectural and metabolic adaptations in muscles with mitochondrial and cystosolic creatin kinase deficiencies. Mol Cell Biochem 184: 183-194, 1998.
32. Steinberg GR, Macaulay SL, Febbraio MA, Kemp BE. AMP-activated protein kinase-the fat controller of the energy railroad. Can J Physiol Pharmacol 84: 655-665, 2006.
33. Stenbit AE, Burcelin R, Katz EB, Tsao TS, Gautier N, Charron MJ, Le Marchand-Brustel Y. Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle. J Clin Invest 98: 629-634, 1996.
34. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45: 28-36, 1996.
35. Tsao TS, Li J, Chang KS, Stenbit AE, Galuska D, Anderson JE, Zierath JR, McCarter RJ, Charron MJ. Metabolic adaptations in skeletal muscle overexpressing GLUT4: effects on muscle and physical activity. FASEB J 15: 958-969, 2001.
36. Tsao TS, Stenbit AE, Li J, Houseknecht KL, Zierath JR, Katz EB, Charron MJ. Muscle-specific transgenic complementation of GLUT4-deficient mice. Effects on glucose but not lipid metabolism. J Clin Invest 100: 671-677, 1997.
37. Voshol PJ, Jong MC, Dahlmans VE, Kratky D, Levak-Frank S, Zechner R, Romijn JA, Havekes LM. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50: 2585-2590, 2001.
38. Way JM, Harrinton WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield Ramachandran RK TA, Willson TM, Kliewer SA. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expresssion in multiple insulin-sensitive tissue. Endocrinology 142: 1269-1277, 2001.
39. Xu ZP, Wawrousek EF, Piatigorsky J. Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice. Mol Cell Biol 22: 6142-6147, 2001.